• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
KALV

KALV

KalVista Pharmaceuticals, Inc.

NASDAQHealthcareBiotechnologyUS

USD26.95

+0.01 (+0.04%)

Rating:C+

Company Profile

CEO

Benjamin L. Palleiko

IPO Date

2015-04-09

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$26.95

Prev. Close

$26.94

Day Low

$26.94

Day High

$26.96

52W Low

$9.83

52W High

$26.98

Market Cap

$1.43B

Volume

6.43M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
Analyst Consensus
Buy

Strong Buy

0

Buy

11

Hold

2

Sell

0

Strong Sell

0

Analyst Grades
DateFirmPreviousNew GradeAction
1 May 2026HC Wainwright & Co.BuyNeutraldowngrade
30 Apr 2026NeedhamBuyHolddowngrade
26 Mar 2026CitizensMarket OutperformMarket Outperformmaintain
26 Mar 2026
Stifel
Buy
Buy
maintain
25 Mar 2026NeedhamBuyBuymaintain
9 Jan 2026HC Wainwright & Co.BuyBuymaintain
9 Jan 2026NeedhamBuyBuymaintain
6 Jan 2026NeedhamBuyBuymaintain
4 Dec 2025NeedhamBuyBuymaintain
11 Nov 2025CitizensMarket OutperformMarket Outperformmaintain